The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Regioselective hydroxylation of steroid hormones by human cytochromes P450
Abstract
This article reviews in vitro metabolic activities [including Michaelis constants (Km), maximal velocities (Vmax) and Vmax/Km] and drug-steroid interactions [such as induction and cooperativity (activation)] of cytochromes P450 (P450 or CYP) in human tissues, including liver and adrenal gland, for 14 kinds of endogenous steroid compounds, including allopregnanolone, cholesterol, cortisol, cortisone, dehydroepiandrosterone, estradiol, estrone, pregnenolone, progesterone, testosterone and bile acids (cholic acid). First, we considered the drug-metabolizing P450s. 6β-Hydroxylation of many steroids, including cortisol, cortisone, progesterone and testosterone, was catalyzed primarily by CYP3A4. CYP1A2 and CYP3A4, respectively, are likely the major hepatic enzymes responsible for 2-/4-hydroxylation and 16α-hydroxylation of estradiol and estrone, steroids that can contribute to breast cancer risk. In contrast, CYP1A1 and CYP1B1 predominantly metabolized estrone and estradiol to 2- and 4-catechol estrogens, which are endogenous ultimate carcinogens if formed in the breast. Some metabolic activities of CYP3A4, including dehydroepiandrosterone 7β-/16α-hydroxylation, estrone 2-hydroxylation and testosterone 6β-hydroxylation, were higher than those for polymorphically expressed CYP3A5. Next, we considered typical steroidogenic P450s. CYP17A1, CYP19A1 and CYP27A1 catalyzed steroid synthesis, including hydroxylation at 17α, 19 and 27 positions, respectively. However, it was difficult to predict which hepatic drug-metabolizing P450 or steroidogenic P450 will be mainly responsible for metabolizing each steroid hormone in vivo based on these results. Further research is required on the metabolism of steroid hormones by various P450s and on prediction of their relative contributions to in vivo metabolism. The findings collected here provide fundamental and useful information on the metabolism of steroid compounds.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hepatic xenobiotic-metabolizing members of the CYP superfamily are able to modify steroid hormones and generate a plethora of minor steroid metabolites [116].”
From Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review (2019) · cites this paper as [116]
In the citing paper
“with at least 17 hepatic CYPs potentially participating in the metabolism of steroids [[116], [117], [118]].”
From Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review (2019) · cites this paper as [116]
In the citing paper
“CYP3A4 is the most abundant P450 in the liver (∼30%) (Shimada et al., 1994) and predominantly, though not exclusively, catalyses the 6β-hydroxylation of T and the 16α- and 7α-hydroxylation of DHEA (Niwa et al., 2015).”
From Intracrine androgen biosynthesis, metabolism and action revisited (2018) · cites this paper as Niwa et al., 2015
In the citing paper
“Prostate cells also express CYP3A4 that can inactivate T by conversion to mainly 6βOH-T (with 2β-, 15α/β- and 11β-hydroxyl side product formation (Niwa et al., 2015))”
From Intracrine androgen biosynthesis, metabolism and action revisited (2018) · cites this paper as Niwa et al., 2015
Citations
Cites
Shimada, T., Yamazaki, H., Mimura, M., Inui, Y., & Guengerich, F. P. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22379-5 · Cited by 2,785
Rendić, S., & Carlo, F. J. D. (1997) · Drug Metabolism Reviews · doi:10.3109/03602539709037591 · Cited by 1,165
Functional role of estrogen metabolism in target cells: review and perspectives
Zhu, B. T. (1998) · Carcinogenesis · doi:10.1093/carcin/19.1.1 · Cited by 970
Summary of information on human CYP enzymes: human P450 metabolism data
Rendić, S. (2002) · Drug Metabolism Reviews · doi:10.1081/dmr-120001392 · Cited by 819
Cytochrome b 5 Augments the 17,20-Lyase Activity of Human P450c17 without Direct Electron Transfer
Auchus, R. J., Lee, T. C., & Miller, W. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.6.3158 · Cited by 541
Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7
Williams, J. A., Ring, B. J., Cantrell, V. E., Jones, D. R., Eckstein, J., Ruterbories, K., Hamman, M. A., Hall, S. D., & Wrighton, S. A. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.8.883 · Cited by 471
Lee, A. J., Cai, M. X., Thomas, P. E., Conney, A. H., & Zhu, B. T. (2003) · Endocrinology · doi:10.1210/en.2003-0192 · Cited by 457
Developmental Expression of the Major Human Hepatic CYP3A Enzymes
Stevens, J. C., Hines, R. N., Gu, C., Koukouritaki, S. B., Manro, J. R., Tandler, P. J., & Zaya, M. J. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.054841 · Cited by 368
Gillam, E. M. J., Baba, T., Kim, B., Ohmori, S., & Guengerich, F. P. (1993) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1993.1401 · Cited by 340
Yamazaki, H., & Shimada, T. (1997) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1997.0302 · Cited by 310
Research works printed but not linked: 6
- Cheng Z, 2000, Acta Pharmacol Sin, 22, 148
- Kenworthy KE, 2001, Drug Metab Dispos, 29, 1644
- Lee AJ, 2003, Cancer Res, 63, 6532
- Mulatero P, 1998, J Clin Endocrinol Metab, 83, 3996
- Niwa T, 2009, Curr Drug Metab, 9, 20
- Ohmori S, 1998, Res Commun Mol Pathol Pharmacol, 100, 15
Cited by
Sorted by citations
Schiffer, L., Barnard, L., Baranowski, E. S., Gilligan, L. C., Taylor, A. E., Arlt, W., Shackleton, C. H. L., & Storbeck, K.-H. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105439 · Cited by 450
“2, hepatic xenobiotic-metabolizing members of the CYP superfamily are able to modify steroid hormones and generate a plethora of minor steroid metabolites [116].”
Sex‐specificity in lung cancer risk
Stapelfeld, C., Dammann, C., & Maser, E. (2019) · International Journal of Cancer · doi:10.1002/ijc.32716 · Cited by 225
Intracrine androgen biosynthesis, metabolism and action revisited
Schiffer, L., Arlt, W., & Storbeck, K.-H. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.08.016 · Cited by 217
“Prostate cells also express CYP3A4 that can inactivate T by conversion to mainly 6bOH-T (with 2b-, 15a/b- and 11b-hydroxyl side product formation (Niwa et al., 2015)) and a decrease of CYP3A4 expression is observed in prostate cancer (Fujimura et al.”
Arzuaga, X., Smith, M. T., Gibbons, C. F., Skakkebæk, N. E., Yost, E. E., Beverly, B., Hotchkiss, A. K., Hauser, R. B., de Souza, R. P., Schrader, S. M., et al. (2019) · Environmental Health Perspectives · doi:10.1289/ehp5045 · Cited by 90
Liver and Steroid Hormones—Can a Touch of p53 Make a Difference?
Charni‐Natan, M., Aloni-Grinstein, R., Osher, E., & Rotter, V. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00374 · Cited by 91
Rendić, S., & Guengerich, F. P. (2021) · Archives of Toxicology · doi:10.1007/s00204-020-02971-4 · Cited by 85
Arana‐Peña, S., Carballares, D., Berenguer‐Murcia, Á., Alcántara, A. R., Rodrigues, R. C., & Fernández‐Lafuente, R. (2020) · Catalysts · doi:10.3390/catal10060605 · Cited by 81
Chen, W.-Y., Fisher, M. J., Leung, A., Cao, Y., & Wong, L. (2020) · ACS Catalysis · doi:10.1021/acscatal.0c02077 · Cited by 69
Jozwik, I. K., Kiss, F. M., Gricman, Ł., Abdulmughni, A., Brill, E., Zapp, J., Pleiss, J., Bernhardt, R., & Thunnissen, A. M. W. H. (2016) · FEBS Journal · doi:10.1111/febs.13911 · Cited by 60
Natural Products That Target Cancer Stem Cells.
Moselhy, J., Srinivasan, S., Ankem, M. K., & Damodaran, C. (2015) · PubMed · Cited by 57
Borrell, M., Gil‐Caballero, S., Bietti, M., & Costas, M. (2020) · ACS Catalysis · doi:10.1021/acscatal.9b05423 · Cited by 57
CYP1B1 as a therapeutic target in cardio-oncology
Carrera, A. N., Grant, M. K. O., & Zordoky, B. N. M. (2020) · Clinical Science · doi:10.1042/cs20200310 · Cited by 44
Liu, Z., Huang, J., Gu, Y., Clark, D. S., Mukhopadhyay, A., Keasling, J. D., & Hartwig, J. F. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.1c10975 · Cited by 44
Toselli, F., Dodd, P. R., & Gillam, E. M. J. (2016) · Drug Metabolism Reviews · doi:10.1080/03602532.2016.1221960 · Cited by 36
de Rond, T., Gao, J., Zargar, A., de Raad, M., Cunha, J., Northen, T. R., & Keasling, J. D. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201901782 · Cited by 36
Zheng, R., Shen, H., Li, J., Zhao, J., Lu, L., Hu, M., Lin, Z., Ma, H., Tan, H., Hu, M., et al. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115824 · Cited by 35
Stucki, D., Krahl, H., Walter, M., Steinhausen, J., Hommel, K., Brenneisen, P., & Stahl, W. (2020) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2020.108383 · Cited by 35
Huang, K., Cai, H., Bao, J., & Wu, L. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101132 · Cited by 37
Gut Microbiome Alters the Activity of Liver Cytochromes P450 in Mice With Sex-Dependent Differences
Jourová, L., Vavrečková, M., Zemanová, N., Anzenbacher, P., Langová, K., Hermanová, P. P., Hudcovic, T., & Anzenbacherová, E. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01303 · Cited by 36
The consequence and mechanism of dietary flavonoids on androgen profiles and disorders amelioration
Hu, X., Li, X., Deng, P., Zhang, Y., Liu, R., Cai, D., Xu, Q., Jiang, X., Sun, J., & Bai, W. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2090893 · Cited by 36
Selective Hydroxylation of C(sp3)−H Bonds in Steroids
Abas, H., Blencowe, P., Brookfield, J. L., & Harwood, L. A. (2023) · Chemistry - A European Journal · doi:10.1002/chem.202301066 · Cited by 31
Khatri, Y., Ringle, M., Lisurek, M., von Kries, J. P., Zapp, J., & Bernhardt, R. (2015) · ChemBioChem · doi:10.1002/cbic.201500420 · Cited by 32
Genotoxicity of ortho-quinones: reactive oxygen species versus covalent modification
Penning, T. M. (2017) · Toxicology Research · doi:10.1039/c7tx00223h · Cited by 29
Comparison of steroid hormone hydroxylation mediated by cytochrome P450 3A subfamilies
Niwa, T., Okamoto, A., Narita, K., Toyota, M., Kato, K., Kobayashi, K., & Sasaki, S. (2020) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2020.108283 · Cited by 28
Niwa, T., Morimoto, M., Hirai, T., Hata, T., Hayashi, M., & Imagawa, Y. (2016) · The Journal of Toxicological Sciences · doi:10.2131/jts.41.143 · Cited by 28
Wu, J.-J., Cao, Y., Feng, L., He, Y., Hong, J. Y., Dou, T., Wang, P., Hao, D., Ge, G., & Yang, L. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00001 · Cited by 28
Zhang, J., Gao, L.-Z., Chen, Y.-J., Zhu, P.-P., Yin, S.-S., Su, M., Ni, Y., Miao, J., Wu, W.-L., Chen, H., et al. (2019) · Drug Metabolism and Disposition · doi:10.1124/dmd.118.085670 · Cited by 29
Uehara, S., Uno, Y., Nakanishi, K., Ishii, S., Inoue, T., Sasaki, E., & Yamazaki, H. (2017) · Drug Metabolism and Disposition · doi:10.1124/dmd.116.074898 · Cited by 26
Mascia, F., Pereira, S. B., Pacheco, C. C., Oliveira, P., Solarczek, J., Schallmey, A., Kourist, R., Alphand, V., & Tamagnini, P. (2022) · Green Chemistry · doi:10.1039/d1gc04714k · Cited by 27
Xu, X., Bai, G., Song, L., Zheng, Q., Yao, Y., Liu, S., & Yao, C. (2017) · Electrochimica Acta · doi:10.1016/j.electacta.2017.11.195 · Cited by 23
Xu, X., Zheng, Q., Bai, G., Dai, Q., Cao, X., Yao, Y., Liu, S., & Yao, C. (2018) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2018.08.009 · Cited by 24
Bromek, E., & Daniel, W. A. (2021) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2021.1872543 · Cited by 24
Zhu, R., Liu, Y., Yang, Y., Min, Q., Li, H., & Chen, L. (2022) · Advanced Synthesis & Catalysis · doi:10.1002/adsc.202200210 · Cited by 23
Liang, Z., Jiao, W., Wang, L., Chen, Y., Li, D., Zhang, Z., Zhang, Z., Liang, Y., & Niu, H. (2022) · Experimental Cell Research · doi:10.1016/j.yexcr.2022.113279 · Cited by 22
Chen, Y., Zhang, J., Zhu, P.-P., Xian-wen, T., Lin, Q.-H., Wang, W., Yin, S.-S., Gao, L.-Z., Su, M., Liu, C., et al. (2019) · Drug Metabolism and Disposition · doi:10.1124/dmd.119.086637 · Cited by 21
A CYPome-wide study reveals new potential players in the pathogenesis of Parkinson’s disease
Hartz, P., Fehlmann, T., Wagenpfeil, G., Unger, M. M., & Bernhardt, R. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1094265 · Cited by 21
Comparison of Steroid Hormone Hydroxylations by and Docking to Human Cytochromes P450 3A4 and 3A5
Niwa, T., Narita, K., Okamoto, A., Murayama, N., & Yamazaki, H. (2019) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/jpps30558 · Cited by 21
Steroids hydroxylation catalyzed by the monooxygenase mutant 139-3 from Bacillus megaterium BM3
Liu, X., & Kong, J. (2017) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2017.04.006 · Cited by 20
Effects of xenobiotics on CYP1 enzyme-mediated biotransformation and bioactivation of estradiol
Mao, X., Li, H., & Zheng, J. (2023) · Drug Metabolism Reviews · doi:10.1080/03602532.2023.2177671 · Cited by 20
Villeneuve, D. L., Blackwell, B. R., Cavallin, J. E., Cheng, W., Feifarek, D. J., Jensen, K. M., Kahl, M. W., Milsk, R. Y., Poole, S. T., Randolph, E. C., et al. (2020) · Environmental Toxicology and Chemistry · doi:10.1002/etc.4968 · Cited by 20
AhR governs lipid metabolism: the role of gut microbiota
Zheng, W., Liu, M., Lv, X., He, C., Yin, J., & Ma, J. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1442282 · Cited by 21
Dai, Q., Yang, L., Wang, Y., Cao, X., Yao, C., & Xu, X. (2020) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-020-02727-0 · Cited by 19
Wang, Q., Ma, B., Fushinobu, S., Zhang, C., & Xu, L. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.11.091 · Cited by 18
Characterization of a Novel CYP1A2 Knockout Rat Model Constructed by CRISPR/Cas9
Sun, D., Lu, J., Zhang, Y., Liu, J., Liu, Z., Yao, B., Guo, Y., & Wang, X. (2021) · Drug Metabolism and Disposition · doi:10.1124/dmd.121.000403 · Cited by 19
Marie, S., Frost, K. L., Hau, R. K., Martinez-Guerrero, L., Izu, J. M., Myers, C. M., Wright, S. H., & Cherrington, N. J. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.08.018 · Cited by 18
Structure–function analysis for the hydroxylation of Δ4 C21‐steroids by the myxobacterial CYP260B1
Salamanca-Pinzon, S. G., Khatri, Y., Carius, Y., Keller, L., Müller, R., Lancaster, C. R. D., & Bernhardt, R. (2016) · FEBS Letters · doi:10.1002/1873-3468.12217 · Cited by 18
Adachi, K., Ohyama, K., Tanaka, Y., Sato, T., Murayama, N., Shimizu, M., Saito, Y., & Yamazaki, H. (2022) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2022.100486 · Cited by 17
Characterization of Maternal and Fetal CYP3A-Mediated Progesterone Metabolism
Quinney, S. K., Benjamin, T. D., Zheng, X., & Patil, A. S. (2017) · Fetal and Pediatric Pathology · doi:10.1080/15513815.2017.1354411 · Cited by 16
Niwa, T., & Hata, T. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2016.01.007 · Cited by 15
Niwa, T., Shizuku, M., & Yamano, K. (2017) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2017.03.009 · Cited by 15
Arabnezhad, M., Montazeri‐Najafabady, N., Chatrabnous, N., Ghaffarian‐Bahraman, A., & Mohammadi‐Bardbori, A. (2019) · Steroids · doi:10.1016/j.steroids.2019.108508 · Cited by 15
Perreault, M., Maltais, R., Dutour, R., & Poirier, D. (2016) · Steroids · doi:10.1016/j.steroids.2016.08.015 · Cited by 15
Novel regulation of the transcription factor ZHX2 by N-terminal methylation
Conner, M. M., Parker, H. V., Falcone, D. R., Chung, G., & Tooley, C. E. S. (2022) · Transcription · doi:10.1080/21541264.2022.2079184 · Cited by 14
Goh, J. J. N., Behn, J., Chong, C., Zhong, G., Maurer‐Stroh, S., Fan, H., & Loo, L. (2021) · Archives of Toxicology · doi:10.1007/s00204-021-03111-2 · Cited by 13
Novel Cytochrome P450 2C94 Functionally Metabolizes Diclofenac and Omeprazole in Dogs
Uno, Y., Morikuni, S., Shiraishi, M., Asano, A., Murayama, N., & Yamazaki, H. (2023) · Drug Metabolism and Disposition · doi:10.1124/dmd.122.001236 · Cited by 13
Mao, Y., 中国科学院神经科学研究所神经科学国家重点实验室, 脑., Li, Y., Yang, Z., Xu, N., Zhang, S., Wang, X., Yang, X., Sun, Q., Mao, Y., et al. (2023) · 动物学研究 · doi:10.24272/j.issn.2095-8137.2023.322 · Cited by 15
Ye, X., Peng, T., Li, Y., Huang, T., Wang, H., & Hu, Z. (2021) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2021.106025 · Cited by 13
Kuhn, M. J., Mavangira, V., & Sordillo, L. M. (2020) · Journal of Dairy Science · doi:10.3168/jds.2020-18997 · Cited by 14
Saba, N., & Seal, A. (2018) · Journal of Molecular Modeling · doi:10.1007/s00894-018-3611-1 · Cited by 11
Ma, W., Dang, D. X., Zhang, J., Wang, C., & Li, D. (2022) · Journal of Animal Physiology and Animal Nutrition · doi:10.1111/jpn.13714 · Cited by 11
CYP2S1 and CYP2W1 expression is associated with patient survival in breast cancer
Aiyappa‐Maudsley, R., Storr, S. J., Rakha, E. A., Green, A. R., Ellis, I. O., & Martin, S. G. (2022) · The Journal of Pathology Clinical Research · doi:10.1002/cjp2.291 · Cited by 11
Effects of Shengmai San on key enzymes involved in hepatic and intestinal drug metabolism in rats
Chiang, T.-Y., Wang, H.-J., Wang, Y.-C., Tan, E. C., Lee, I., Yun, C., & Ueng, Y. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.113914 · Cited by 11
Li, J., Tang, Y., Li, W., & Tu, Y. (2020) · Chemistry - A European Journal · doi:10.1002/chem.201905272 · Cited by 11
Pardhe, B. D., Kwon, K. P., Park, J. K., Lee, J. H., & Oh, T. (2022) · Applied and Environmental Microbiology · doi:10.1128/aem.01585-22 · Cited by 11
A patent review of CYP3A4 inhibitors (2018 – present)
Tu, D., Hu, X., Lei, J.-X., Liu, S., Xiao, Z.-P., Yang, L., & Ge, G. (2025) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2025.2470294 · Cited by 10
Gjorgoska, M., & Rižner, T. L. (2024) · Progress in Lipid Research · doi:10.1016/j.plipres.2024.101302 · Cited by 9
Niwa, T., & Imagawa, Y. (2016) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j31s53 · Cited by 9
Wang, J., Li, K., Zhang, X., Teng, D., Ju, M., Jing, Y., Zhao, Y., & Li, G. (2017) · Scientific Reports · doi:10.1038/s41598-017-02698-w · Cited by 9
de Rond, T., Gao, J., Zargar, A., de Raad, M., Cunha, J., Northen, T. R., & Keasling, J. D. (2019) · Angewandte Chemie · doi:10.1002/ange.201901782 · Cited by 10
Fitch, W. L., Smith, S. M., Saporito, M. S., Busse, G., Zhang, M., Ren, J., Fitzsimmons, M. E., Yi, P. C., English, S., Carter, A. N., et al. (2023) · Drug Metabolism and Disposition · doi:10.1124/dmd.122.001218 · Cited by 9
Mo, H.-Y., Wei, Q.-Y., Zhong, Q.-H., Zhao, X.-Y., Guo, D., Han, J., Noracharttiyapot, W., Visser, L., van den Berg, A., Xu, Y., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147853 · Cited by 8
Hummel, K., Gupta, S., Silva, A. M., Garcia, S. P., Odhiambo, D. H., Sygit, D., Cai, J., Ward, C. L., Kocarek, T. A., Sokolov, A. Y., et al. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c11695 · Cited by 7
Zhang, Y., Chen, Y., Dai, B., Bai, M., Lu, S., Lin, N., Zhou, H., & Jiang, H. (2022) · Drug Metabolism and Disposition · doi:10.1124/dmd.121.000685 · Cited by 7
Niwa, T., & Sugimoto, S. (2019) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/jpps30622 · Cited by 7
Цейликман, В. Э., Manukhina, E. B., Downey, H. F., Tseilikman, O. B., Misharina, M. E., Nikitina, A. A., Komelkova, M. V., Lapshin, M. S., Kondashevskaya, М. V., Lazuko, S. S., et al. (2016) · General Physiology and Biophysics · doi:10.4149/gpb_2015039 · Cited by 7
Su, W.-Y., Meng, W., Kong, L.-N., Chang, S., Zhang, J., Chang, Y., & Sun, Z. (2024) · Aquaculture Reports · doi:10.1016/j.aqrep.2024.102137 · Cited by 6
Huang, S., Xu, Y., Guo, Y., Zhang, Y., Tang, Y. C., Liang, C., Gao, L., Yao, B., & Wang, X. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116561 · Cited by 6
Shrivastava, P., Mondal, S., Thakur, S., Manhas, A., & Mehra, R. (2025) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.4c00387 · Cited by 6
Niwa, T., Toyota, M., Kawasaki, H., Ishii, R., & Sasaki, S. (2021) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b20-00987 · Cited by 6
Wang, C., Cheng, B., Wei, W., Gui, L., Zeng, W., Wang, Y., Wang, Y., Chen, Q., Xu, L., Miao, J., et al. (2023) · Drug Metabolism and Disposition · doi:10.1124/dmd.123.001513 · Cited by 5
Study specificity of isatin interactions with P450 cytochromes
Ershov, P. V., Mezentsev, Y. V., Yablokov, E. O., Kalushskiy, L. A., Florinskaya, A. V., Svirid, A. V., Gilep, A. A., Usanov, S. A., Medvedev, A. E., & Ivanov, A. S. (2018) · Biomeditsinskaya Khimiya · doi:10.18097/pbmc20186401061 · Cited by 5
Kalimuthu, P., Wojtkiewicz, A. M., Szaleniec, M., & Bernhardt, P. V. (2018) · Chemistry - A European Journal · doi:10.1002/chem.201800616 · Cited by 6
Mechanistic considerations for reduced endometrial cancer risk by smoking
van den Berg, M., & van Duursen, M. B. M. (2019) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2019.09.002 · Cited by 5
SFC‐MS/MS for orthogonal separation of hydroxylated 17α‐methyltestosterone isomers
Bredendiek, F., & Parr, M. K. (2023) · Drug Testing and Analysis · doi:10.1002/dta.3620 · Cited by 5
Specificity of Isatin Interaction with Cytochromes P450
Ershov, P. V., Mezentsev, Y. V., Yablokov, E. O., Kaluzhskiy, L. A., Florinskaya, A. V., Svirid, A. V., Gilep, A. A., Usanov, S. A., Medvedev, A. E., & Ivanov, A. S. (2018) · Biochemistry (Moscow) Supplement Series B Biomedical Chemistry · doi:10.1134/s1990750818020026 · Cited by 4
Awareness and acceptance of hepatitis B vaccination in Clementi, Singapore.
Fong, N. P., Basir, H., & Seow, A. (1990) · PubMed · Cited by 4
Niwa, T., Tani, M., Suzuki, A., & Murakami, M. (2023) · Drug Metabolism and Bioanalysis Letters · doi:10.2174/2949681016666230830125358 · Cited by 3
Effect of Human Cytochrome P450 2D6 Polymorphism on Progesterone Hydroxylation
Niwa, T., Sasaki, S., Yamamoto, Y., & Tanaka, M. (2022) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-022-00784-7 · Cited by 3
Matáková, T., Halasova, E., Dzian, A., Hruby, R., Halaša, M., Javorka, K., & Škereňová, M. (2016) · Advances in experimental medicine and biology · doi:10.1007/5584_2016_220 · Cited by 3
Niwa, T., Arima, J., & Michihiro, Y. (2021) · Xenobiotica · doi:10.1080/00498254.2021.1989520 · Cited by 3
Pukło, R., Bromek, E., Basińska-Ziobroń, A., Haduch, A., Kuban, W., Danek, P. J., & Daniel, W. A. (2025) · Drug Metabolism and Disposition · doi:10.1016/j.dmd.2025.100143 · Cited by 2
Covalent inhibitors of human cytochrome P450 3A4: research advances and future perspectives
Tu, D., Xiao, Z.-P., Liu, S., Hu, X., Lei, J.-X., Gong, J.-H., Zhang, F., Ding, X., Dai, Z., Zheng, J., et al. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.217028 · Cited by 2
Mechanism-Based Inhibition of CYP3A Subfamilies by Macrolide Antibiotics and Piperine
Niwa, T., & Ishii, R. (2022) · Drug Metabolism and Bioanalysis Letters · doi:10.2174/2949681015666220804103005 · Cited by 2
Subedi, P., Do, H., Lee, J. H., & Oh, T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113317 · Cited by 2
Zhang, S., Wang, T., Feng, Y., Li, F., Qu, A., Guan, X., Wang, H., & Xu, D. (2023) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2023.07.013 · Cited by 2
Kong, L., Abudula, A., Cong, J., Meng, W., Chang, Y., & Sun, Z. (2025) · Aquaculture International · doi:10.1007/s10499-025-01862-8 · Cited by 2
Kazakova, O. A., & Dolgikh, О. V. (2021) · Russian Journal of Immunology · doi:10.46235/1028-7221-243-pri · Cited by 2
Chang, K., Jiang, Z., Liu, C., Ren, J., Wang, T., & Xiong, J. (2016) · Medicine · doi:10.1097/md.0000000000004954 · Cited by 2
Bhatia, K. S., Mahesh, A. N., & Bhatt, S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-824315-2.00696-5 · Cited by 2
Molecular plasticity contributes to thermal resilience in two coastal fish speciesPreprint
Riordan, B., Dutoit, L., King, T. M., Beheregaray, L. B., Gemmell, N. J., Hickey, A. J., & Johnson, S. L. (2024) · doi:10.32942/x2hp6f · Cited by 2
Metadata
- Authors
- Niwa, T., Murayama, N., Imagawa, Y., & Yamazaki, H.
- Affiliations
- Shujitsu University (JP)
- Showa Pharmaceutical University (JP)
- Corresponding author
- Yamazaki, Hiroshi
- Venue
- Drug Metabolism Reviews
- Publisher
- Informa UK Limited
- Published
- 2015-02-13
- Volume
- 47
- Issue
- 2
- Pages
- 89-110
- ISSN
- 0360-2532 (ISSN-L)
- 1097-9883
- OpenAlex
- W2041685866
- Cited by
- 121
- References
- 88
- Citations by year
- 2026: 7 · 2025: 12 · 2024: 7 · 2023: 12 · 2022: 18 · 2021: 10 · 2020: 13 · 2019: 14 · 2018: 5 · 2017: 10 · 2016: 10 · 2015: 2
- FWCI
- 1.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Drug Metabolism Reviews (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Physical Sciences › Chemistry › Organic Chemistry › Steroid Chemistry and Biochemistry
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- steroid hormone metabolism, cytochrome P450, regioselective hydroxylation, CYP3A4, CYP1A2, CYP1A1, CYP1B1, CYP17A1, CYP19A1, CYP27A1, CYP3A5, enzyme induction, cooperativity, estradiol, estrone, catechol estrogens, breast cancer risk, steroidogenesis, adrenal gland, liver
- MeSH terms
- Adrenal Glands, Cholesterol, Cytochrome P-450 Enzyme System, Estradiol, Humans, Hydroxylation, Liver, Testosterone, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review